Number

Shortcode

Scope

Section

Intention
100 About DRCBB About this Report Section for data identification purposes
101 General DRCBB General HLA typed and listed unrelated donor/CBU/ADCU data Section for gaining statistics and insight into current global unrelated donor/CBU/ADCU inventory for transplantation
105 New Delete DR HLA typed unrelated donors/CBUs/ADCUs newly listed and permanently deleted by your organisation Section for gaining statistics and insight into growth of global unrelated donor/CBU/ADCU inventory for transplantation and reasons for permanent deletion of previously listed unrelated donor/CBU/ADCU.
110 Age Sex DR Age and biological sex of HLA typed unrelated donors listed by your organisation Section for tracking demographics of current global unrelated donor inventory for transplantation
130 Prospective typing DRCBB Prospective typing strategy and strategy to improve typing of your existing HLA typed and previously listed unrelated donors/CBUs Section for gaining insight into current prospective HLA typing strategies and global efforts to improve HLA typing of previously listed unrelated donor/CBU inventory for transplantation
140 HAC DR Health and availability check (HAC) for your HLA typed and listed unrelated donors (prior to/without collection of blood sample for extended typing) Section for tracking development and use of new methods during ET/VT/WU for unrelated donor
150 ET DR Extended typing (ET) requests completed from your HLA typed and listed unrelated donors Section for tracking development, use and time required of ET for unrelated donor
170 VT DR Blood samples requests provided from your HLA typed and listed unrelated donors for verification typing (VT) Section for tracking development, time required and cancellation reasons of VT for unrelated donor. Please note that the answers in this section are used to calculate your KPIs
180 WU DR Work-up (WU) requested from your HLA typed and listed unrelated donors Section for tracking development of unrelated donor WU and their reasons for cancellation. Please note that the answers in this section are used to calculate your KPIs
190 CBU ET/VT CBB Verification typings (VT) and extended typings (ET) of your HLA typed and listed unrelated CBUs Section for tracking development, time required and cancellation reasons of ET and VT for unrelated CBU
200 CBU shipped CBB CBUs shipped by your organisation for unrelated patients Section for tracking global statistics on unrelated CBU shipments and reasons for not transplanting
220 CBU pediatric CBB CBUs shipped for unrelated pediatric patients (16 years or below) Section for tracking global development of unrelated CBU use in pediatric patients per transplant type
240 CBU adults CBB CBUs shipped for unrelated adult patients (over 16 years) Section for tracking global development of unrelated CBU use in adult patients per transplant type
260 CBU cancel CBB Cancellations of CBUs ordered Section for tracking global statistics of reasons for CBU cancellation after ordering
280 CBU TNC CBB Post-processing, pre-freezing total nucleated cell (TNC) count of unrelated CBUs provided for transplantation Section for gaining insight into TNC counts of unrelated CBU used for transplantation, which may be used for CBU banking policies
500 ADCU VT DR Verification typings (VT) of your ADCUs Section for tracking global statistics of VT for unrelated ADCU
510 ADCU shipped DR ADCUs shipped by your organisation for unrelated patients Section for tracking global statistics on unrelated ADCU shipments and reasons for not transplanting
530 ADCU cancel DR Cancellations of ADCUs ordered Section for tracking global statistics of reasons for ADCU cancellation after ordering
550 ADCU CD34 DR Post-processing, pre-freezing CD34+ absolute count of unrelated ADCU provided for transplantation Section for gaining insight into CD34+ counts of unrelated ADCU used for transplantation, which may be used for ADCU banking policies
600 HPC shipped DRCBB Distribution of unrelated HPC/MNC donor products shipped Section for gaining insight into global exchange of unrelated HPC/MNC donor products and calculating import/export and self-sufficiency ratios of countries and individual organisations.
610 HPC import DRCBB Distribution of unrelated HPC/MNC donor products imported Section for gaining insight into global exchange of unrelated HPC/MNC donor products and calculating import/export and self-sufficiency ratios of countries and individual organisations.
620 First Subsequent DRCBB Unrelated HPC/MNC donations provided by your organisation for first and subsequent donations Section for tracking development of unrelated HPC/MNC donations for first and subsequent donation
630 Unrelated patients DRCBB Patients received unrelated transplant Section for gaining global statistics on unrelated transplantation
700 No registry DRCBB Patients received unrelated transplant in country without national registry Section for gaining insight into facilitation of unrelated transplants in underserved regions
750 Related patients DRCBB Patients received related transplant Section for gaining insight into facilitation of related transplantation by unrelated donor organisations
810 HLA Discrepancies DRCBB HLA Discrepancies in unrelated donors/CBU (do not include patients or related donors) Section for tracking development of HLA discrepancies in unrelated donor/CBU HLA typing. Please note that the answers in this section are used to calculate your KPIs
820 OB DR Work-ups (WU) requested from your unrelated donors for Peripheral Blood Stem Cells (PBSC, HPC, Apheresis) collections only Section for gaining insight into global apheresis center availability (Orca Bio sponsored question)
  • No labels